Chediak-Higashi, Hemoglobin Lansing ve Hemoglobin Jabalpur Hakkında

Journal Title: Turkish Journal of Hematology - Year 2015, Vol 32, Issue 1

Abstract

Authors and Affiliations

Şinasi Özsoylu

Keywords

Related Articles

FLAG Regimen with or without Idarubicin in Children with Relapsed/Refractory Acute Leukemia: Experience from a Turkish Pediatric Hematology Center

Objective: The optimal therapy to achieve higher rates of survival in pediatric relapsed/refractory acute leukemia (AL) is still unknown. In developing countries, it is difficult to obtain some of the recent drugs for op...

Subcutaneous Myeloma Deposit in the Region of an Arteriovenous Fistula

Subcutaneous Myeloma Deposit in the Region of an Arteriovenous Fistula

Rituximab-Related Reversible Hepatocellular Damage

To the Editor, Since its approval in 1997 by the US Food and Drug Administration, use of rituximab (MabThera®, Roche,Switzerland) has become widespread, especially for the treatment of non-Hodgkin lymphoma (NHL) and chr...

Download PDF file
  • EP ID EP163425
  • DOI 10.4274/tjh.2014.0393
  • Views 83
  • Downloads 0

How To Cite

Şinasi Özsoylu (2015). Chediak-Higashi, Hemoglobin Lansing ve Hemoglobin Jabalpur Hakkında. Turkish Journal of Hematology, 32(1), 90-91. https://europub.co.uk/articles/-A-163425